Implantable medical devices and methods for making same

• US 7,572,298 B2
• Filed: 03/28/2003
• Issued: 08/11/2009
• Est. Priority Date: 03/28/2003
• Status: Active Grant

• Current Assignee: Ethicon Incorporated (Johnson & Johnson)
• Original Assignee: Ethicon Incorporated (Johnson & Johnson)
• Inventors: Li, Yufu, Yuan, Jenny J., Roller, Mark B.
• Primary Examiner(s): Robert; Eduardo C
• Assistant Examiner(s): COMSTOCK, DAVID C
• Application Number:
  US10/401,914
• Publication Number:
  US 20040193285A1
• Time in Patent Office: 2,328 Days
• Field of Search: 606 60- 61, 606 72- 73, 606/77, 623/23.51, 623/23.75, 523/113, 523/115, 525/450, 525/937, 528/354, 524/414
• US Class Current: 623/23.75
• CPC Class Codes: A61B 17/0401 Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors A61B17/0642 takes precedence; fixation devices for tendons or ligaments A61F2/0811
• CPC Class Codes: A61B 2017/00004 (bio)absorbable, (bio)resorbable, resorptive for implantable prostheses A61F2210/0004
• CPC Class Codes: A61B 2017/044 with a threaded shaft, e.g. screws
• CPC Class Codes: A61L 27/50 Materials characterised by their function or physical properties , e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
• CPC Class Codes: A61L 31/14 Materials characterised by their function or physical properties , e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials

Abstract

An implantable medical device is disclosed. The device is fabricated at least in part from a biocompatible, biodegradable composition. The composition is composed of a biocompatible, biodegradable polymer and a biocompatible, biodegradable wax. The concentration of the wax at the surface of the device is greater than the concentration of the wax in the body of the implantable device. The increased concentration of wax at the device surface may be attained when the device is heated to a temperature greater than the melting point of the wax and the glass transition temperature of the polymer, but lower than melting point of the polymer.

Claims

1. An implantable medical device, comprising:

a body and a first lubricated surface for contacting tissue, or a second surface of said device, or a surface of a second medical device, the implantable device comprising a biocompatible, biodegradable composition, the composition comprising a biocompatible, biodegradable polymer having a glass transition temperature and a melting point and a biocompatible, biodegradable wax having a melting point, said biocompatible, biodegradable wax present in an amount greater than about 5% by weight, wherein;

a) the wax is selected from the group consisting of homopolymers and copolymers of lactide, glycolide, epsilon-caprolactone, para-dioxanone, trimethylene carbonate, alkyl derivatives of trimethylene carbonate and monoglyceride polyesters having an inherent viscosity of less than about 0.7 g/dl as measured in chloroform at 25°

C.; and

b) the concentration of the wax at the first lubricated surface of the implantable device is greater than the concentration of the wax in the body of the implantable device and is achieved by heat treatment of the device at a temperature that is above the melting point of the wax and the glass transition temperature of the polymer and lower than the melting point of the polymer, thereby providing the lubricated surface.

2. The medical device of claim 1 wherein the biodegradable polymer is selected from the group consisting of aliphatic polyesters, poly(amino acids), copoly(ether-esters), polyalkylenes oxalates, polyamides, poly(ethylene glycol), poly(iminocarbonates), polyorthoesters, polyoxaesters, polyamidoesters, polyoxaesters containing amine groups, poly(anhydrides), polyphosphazenes, biopolymers and copolymers thereof.

3. The medical device of claim 2 wherein the aliphatic polyester is selected from the group consisting of homopolymers and copolymers of lactide, glycolide, epsilon-caprolactone, para-dioxanone, trimethylene carbonate, alkyl derivatives of trimethylene carbonate and monoglyceride polyesters.

4. The medical device of claim 3 wherein the aliphatic polyester comprises a copolymer of from about 80 to 99 mole percent lactide and glycolide.

5. The medical device of claim 4 wherein the aliphatic polyester has an inherent viscosity of greater than about 2.0 g/dl as measured in chloroform at 25°

C.

6. The medical device of claim 1 wherein the wax comprises a copolymer of from about 90 to about 10 mole percent epsilon-caprolactone and glycolic acid.

7. The medical device of claim 1 further comprising an inorganic filler material.

8. The medical device of claim 7 wherein said inorganic filler material is selected from the group consisting of mono-, di-, tri-, α

-tri-, β

-tri-, and tetra-calcium phosphate, hydroxyapatite, fluoroapatites, calcium sulfates, calcium fluorides, calcium oxides, calcium carbonates, magnesium calcium phosphates and bio-glasses.

9. The medical device of claim 8 selected from the group consisting of reinforcing rods, plates, cages, screws, pins, anchors, expanding sleeves and expanding collars.

10. The medical device of claim 9 wherein the anchor comprises a radially-expandable sheath and a sheath-expanding element.